Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Dec 15, 2023; 15(12): 2120-2137
Published online Dec 15, 2023. doi: 10.4251/wjgo.v15.i12.2120
Published online Dec 15, 2023. doi: 10.4251/wjgo.v15.i12.2120
Figure 1 The impacts of curcumin treatment on colorectal carcinoma (SW480 and SW620) cell proliferation and apoptosis.
Colorectal carcinoma (CRC) cells were treated with DMSO or curcumin (20 μM). A: Cell viability was detected in treated or untreated SW480 and SW620 using cell counting kit-8 assays; B and C: Colony number assessment by colony-forming cell assays in treated or untreated SW480 and SW620; D and E: Apoptosis rate analysis in treated or untreated CRC cells by flow cytometry assays; F: Real-time quantitative PCR analysis of hsa_circ_0000392, hsa_circ_0000896, and hsa_circ_0136666 expression in treated or untreated SW480 and SW620 cells. 1P < 0.05.
- Citation: Chen S, Li W, Ning CG, Wang F, Wang LX, Liao C, Sun F. Hsa_circ_0136666 mediates the antitumor effect of curcumin in colorectal carcinoma by regulating CXCL1 via miR-1301-3p. World J Gastrointest Oncol 2023; 15(12): 2120-2137
- URL: https://www.wjgnet.com/1948-5204/full/v15/i12/2120.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i12.2120